Germany Joins Decision To Suspend AZ Vaccine Over Safety, But Is It Really The Most ‘Cautious’ Approach?
Countries At Odds With EMA Guidance
Executive Summary
AstraZeneca’s vaccine is under suspicion again, this time over safety, rather than efficacy, and the European Medicines Agency has promised a swift review.
You may also be interested in...
AstraZeneca CEO Rues Reality Of Vaccine Inequity
The UK major’s hopes of creating a vaccine for the world during the COVID-19 pandemic have been hampered by political self-interest and nationalism, according to a BBC documentary.
AstraZeneca’s COVID-19 Vaccine PR Nightmare Won’t Faze Investors
Comment: While the travails around the COVID-19 vaccine continue, AstraZeneca has plenty in its pipeline to cheer investors.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.